39 Results for "

Acc1

" in MedChemExpress (MCE) Product Catalog:
Products (39)

39 Results for "Acc1" in MCE Product Catalog:

24
24 Publications Verification
Cat. No.: HY-16901
CAS No.: 1434635-54-7
Synonyms: ND-630; GS-0976; NDI-010976
Research Areas:  

Metabolic Disease

Firsocostat (ND-630; GS-0976; NDI-010976) is an acetyl-CoA carboxylase (ACC) inhibitor; inhibits human ACC1 and ACC2 with IC50 values of 2.1 and 6.1 nM, respectively.
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-15259
CAS No.: 591778-68-6
Purity:  99.72%
Research Areas:  

Metabolic Disease

CP-640186 is an orally active and cell-permeable Acetyl-CoA carboxylase (ACC) inhibitor with IC50s of 53 nM and 61 nM for rat liver ACC1 and rat skeletal muscle ACC2 respectively. Acetyl-CoA carboxylase (ACC) is a key enzyme of fatty acid metabolism that enables the synthesis of malonyl-CoA. CP-640186 can also stimulate muscle fatty acid oxidation [1] .
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-15259A
CAS No.: 591778-70-0
Purity:  99.90%
Research Areas:  

Metabolic Disease

CP-640186 hydrochloride is an orally active and cell-permeable Acetyl-CoA carboxylase (ACC) inhibitor with IC50s of 53 nM and 61 nM for rat liver ACC1 and rat skeletal muscle ACC2 respectively. Acetyl-CoA carboxylase (ACC) is a key enzyme of fatty acid metabolism that enables the synthesis of malonyl-CoA. CP-640186 hydrochloride can also stimulate muscle fatty acid oxidation [1] .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-D0067
CAS No.: 50995-74-9
Synonyms: DEAC; Coumarin D 1421; D 1421
Research Areas:  

Cancer

7ACC1 (DEAC; Coumarin D 1421; D 1421) is a monocarboxylate transporter 1 (MCT-1)/MCT-4 specifc blocker. 7ACC1 attenuates renal cancer cell proliferation, migration, invasion and down-regulates the levels of MCT1/MCT4 expression and extracellular lactate. 7ACC1 is promising for research of cancers [1] .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-12741
CAS No.: 894002-50-7
Purity:  98.92%
Synonyms: LDN-0212320; OSU-0212320
Target:  

EAAT

Research Areas:  

Neurological Disease

LDN-212320 (LDN-0212320) is a glutamate transporter (GLT-1)/excitatory amino acid transporter 2 (EAAT2) activator (at translational level). LDN-212320 (LDN-0212320) prevents nociceptive pain by upregulating astroglial GLT-1 expression in the hippocampus and ACC [1]
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-107709
CAS No.: 1039758-22-9
Purity:  99.04%
Research Areas:  

Metabolic Disease

MK-4074 is a liver-specific inhibitor of acetyl-CoA carboxylase ACC1 and ACC2 with IC50 values of approximately 3 nM.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-12942
CAS No.: 1301214-47-0
Purity:  98.46%
Research Areas:  

Metabolic Disease

PF-05175157 is broad spectrum acetyl-CoA carboxylase (ACC) inhibitor with IC50s of 27.0, 33.0, 23.5 and 50.4 nM for ACC1 (human), ACC2 (human), ACC1 (rat), ACC2 (rat), respectively.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-135981
CAS No.: 1353224-53-9
Purity:  98.30%
CMS-121 is a quinolone derivative and an orally active acetyl-CoA carboxylase 1 (ACC1) inhibitor. CMS-121 protects HT22 cells against ischemia and oxidative damage with EC50 values of 7 nM and 200 nM, respectively. CMS-121 has strong neuroprotective, anti-inflammatory, antioxidative and renoprotective activities [1] .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P79193
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Fractalkine; Cx3cl1; C-X3-C motif chemokine 1; CX3C membrane-anchored chemokine; Neurotactin; Small-inducible cytokine D1; Acc1; Fkn; Scyd1
Species:  
Rat
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P80482

Host:  

Rabbit

Application:  

WB, IHC-P

Reactivity:  

Human, Mouse

loading...
    loading...
Cat. No.: HY-160912
CAS No.: 1135000-36-0
Target:  

ELOVL

Research Areas:  

Metabolic Disease

ELOVL6-IN-5 is an orally active and selective elongase enzyme of long-chain fatty acid family 6 (ELOVL6) inhibitor with IC50 values of 85 nM and 38 nM for human and mouse ELOVL6, respectively. ELOVL6-IN-5 shows >60-fold selectivity over other ELOVL family enzymes (ELOVL1, 2, 3, 5) and no effect on other lipid synthesis enzymes like ACC1, ACC2. ELOVL6-IN-5 reduces hepatic fatty acid composition ratio of C18 to C16 in diet-induced obesity (DIO) and KKAy mice. ELOVL6 inhibition by ELOVL6-IN-5 does not improve insulin resistance. ELOVL6-IN-5 can be used for the research of metabolic disease [1].
loading...
    loading...
Cat. No.: HY-147932
CAS No.: 1031411-94-5
Purity:  99.00%
Research Areas:  

Cancer

ACC1/2-IN-2 (compound PF-3) is a potent ACC1/2 inhibitor with IC50 values of 22 and 48 nM for ACC1 and ACC2, respectively. ACC1/2-IN-2 has antiproliferation activity and can be used for cancer research [1].
loading...
    loading...
Cat. No.: HY-124609
CAS No.: 2071209-49-7
Purity:  99.39%
Research Areas:  

Neurological Disease

CAD031 is an orally active AMPK/ACC1 signaling pathway activator and a derivative of the Alzheimer's disease (AD) targeted agent J147 (HY-13779) (more active than J147 in human neural stem cell assays). CAD031 can cross the blood-brain barrier, activate AMPK and inhibit ACC1, thereby increasing ac-CoA levels, improving mitochondrial function and reducing free fatty acid synthesis. CAD031 has neuroprotective, neurogenesis-promoting and memory-improving activities and can be used in the study of Alzheimer's disease and aging-related neurodegenerative diseases. CAD031 effectively enhances the memory of mice, improves dendritic structure, and stimulates cell division in the germinal zone of the brain of elderly mice [1] .
loading...
    loading...
Cat. No.: HY-179537
CAS No.: 1786406-66-3
CKBA, a derivative of AKBA (HY-N0892) is an inhibitor of acetyl-CoA carboxylase 1 (ACC1), with an IC50 of 5.02 μM. CKBA inhibits the differentiation of Th17 cells and has IC50 values of 3.28 μM for mouse cells and 3.61 μM for human cells. CKBA ointment significantly alleviates psoriasis-like inflammation in mice. CKBA can be used for the study of psoriasis [1].
loading...
    loading...
Cat. No.: HY-147930
CAS No.: 2350219-22-4
Research Areas:  

Cancer

ACC1/2-IN-1 (compound 4s) is a potent ACC1/2 inhibitor with IC50 values of 98.06 and 29.43 nM for ACC1 and ACC2, respectively. ACC1/2-IN-1 can be used for cancer research [1].
loading...
    loading...
Cat. No.: HY-N8144
CAS No.: 95262-48-9
Niga-ichigoside F1, an orally active ursane triterpenoid, has antihyperlipidemic and antioxidant activities. Niga-ichigoside F1 can prevent high-fat diet (HFD)-induced hepatic steatosis [1].
loading...
    loading...
Cat. No.: HY-N10612
CAS No.: 26577-85-5
Petasin inhibits adipogenesis in cell 3T3-F442A with an IC50 of 0.95 μM. Petasin inhibits the expression of lipid synthesis factors ACC1, FAS and SCD1 by inhibiting transcription factors PPARγ and C/EBPα, as well as targeting TRPA1 and TRPV1 channels . Petasin inhibits mitochondrial complex I, thereby inhibiting tumor growth and metastasis. Petasin activates AMPK signaling pathway, participating in regulation of glucose and lipid metabolism. Petasin is orally active [1].
loading...
    loading...
Cat. No.: HY-150191
CAS No.: 2315406-63-2
Research Areas:  

Metabolic Disease

IMA-1 is an inhibitor that inhibits the interaction between arachidonic acid 12-lipoxygenase (ALOX12) and acetyl-CoA carboxylase 1 (ACC1). IMA-1 significantly blocks the progression of diet-induced non-alcoholic steatohepatitis (NASH) in male mice and crab-eating monkeys, and does not cause hyperlipidemia. IMA-1 can be used for the study of NASH [1].
loading...
    loading...
Cat. No.: HY-42632
CAS No.: 2131091-32-0
Research Areas:  

Metabolic Disease

ACC1/2-IN-3 (example 66) is an ACC1 and ACC2 inhibitor with an IC50 value of 1-10 nM for both. ACC1/2-IN-3 can be used for the study of diseases mediated by ACC, such as metabolic disease [1].
loading...
    loading...
Cat. No.: HY-127108
CAS No.: 1434641-55-0
Research Areas:  

Metabolic Disease Cancer

ND-654 is a highly selective acetyl-CoA carboxylase (ACC) inhibitor (IC50: ACC1=3 nM, ACC2=8 nM). ND-654 reduces hepatic lipogenesis, decreases neutrophil recruitment and promotes anti-inflammatory M2 macrophage polarization. ND-654 is promising for research of nonalcoholic steatohepatitis and hepatocellular carcinoma [1].
loading...
    loading...